PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 159 filers reported holding PTC THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,770,000 | -30.4% | 162,274 | -10.6% | 0.00% | -33.3% |
| Q3 2016 | $2,542,000 | +97.5% | 181,471 | -1.0% | 0.00% | +50.0% |
| Q2 2016 | $1,287,000 | +27.3% | 183,317 | +16.8% | 0.00% | +100.0% |
| Q1 2016 | $1,011,000 | -77.4% | 156,956 | +13.5% | 0.00% | -83.3% |
| Q4 2015 | $4,479,000 | +22.7% | 138,246 | +1.1% | 0.01% | +20.0% |
| Q3 2015 | $3,650,000 | -45.5% | 136,688 | -1.8% | 0.01% | -37.5% |
| Q2 2015 | $6,697,000 | +14.7% | 139,146 | +45.1% | 0.01% | 0.0% |
| Q1 2015 | $5,837,000 | +24.8% | 95,918 | +6.2% | 0.01% | +33.3% |
| Q4 2014 | $4,676,000 | +62.2% | 90,328 | +37.9% | 0.01% | +50.0% |
| Q3 2014 | $2,882,000 | +69.8% | 65,486 | +0.9% | 0.00% | +100.0% |
| Q2 2014 | $1,697,000 | +99.9% | 64,901 | +99.9% | 0.00% | +100.0% |
| Q1 2014 | $849,000 | +83.0% | 32,462 | +18.8% | 0.00% | 0.0% |
| Q4 2013 | $464,000 | -17.9% | 27,331 | +3.8% | 0.00% | 0.0% |
| Q3 2013 | $565,000 | – | 26,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |